00:07In 2026, optic nerve atrophy remains one of the most challenging neurological eye conditions to
00:13manage. International regenerative research is now exploring new biological pathways to support
00:20nerve health. Optic nerve atrophy is not a single disease. It results from glaucoma,
00:26ischemic damage, trauma, inflammation, and neurodegenerative disorders.
00:32The damage includes loss of retinal ganglion cells, reduced axonal signaling,
00:37chronic inflammation, and compromised blood supply.
00:41From a regenerative perspective, the key challenge is to protect surviving neurons
00:46and improve the biological environment. True nerve regrowth is highly intricate and
00:52extends beyond simple cell replacement. International human studies increasingly
00:57focus on neuroprotection, immunomodulation, and biological signaling rather than direct
01:02nerve replacement. Most studies remain in preclinical and early clinical phases,
01:08reflecting cautious optimism rather than proven curative solutions.
01:13Mesenchymal stem cells, MSCs, are widely studied for their ability to secrete beneficial biological
01:20molecules. They help modulate immune responses, release neurotrophic factors, and support survival
01:27pathways. Different stem cell types show varying levels of clinical relevance.
01:33MSCs are most studied for safety and support. Neural stem cells remain largely experimental,
01:40while induced pluripedent stem cells are mainly confined to laboratory research due to safety concerns.
01:47Current regenerative strategies focus on stabilization and neuroprotection,
01:51slowing disease progression, rather than reversing vision loss or promising restoration.
01:57Professional consultation ensures that your condition is evaluated within verified scientific
02:02and clinical parameters. At Stem Cell Care India, we provide ethical, structured consultations
02:09to help you understand the science behind your recovery options. Contact us to learn more.
